Dipyridamole for early-onset preeclampsia
Treatments studied
Part of Heart & circulation, Women’s health & pregnancy clinical trials.
This trial tests whether dipyridamole, a medicine that helps improve blood flow, can help manage early-onset preeclampsia and potentially prolong the pregnancy safely. It aims to see if the drug is feasible, how it works in the body, and if it has beneficial effects for both mother and baby.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are pregnant with one baby (not twins or more).
- You have been diagnosed with early-onset preeclampsia between 26 and 33 weeks of pregnancy.
- You are in the hospital for monitoring of you and your baby.
- Your doctor has decided that continuing the pregnancy (expectant management) is safe and appropriate.
- Your blood test shows a high sFlt-1/PlGF ratio (≥85), which is a marker of preeclampsia.
- Your baby is confirmed to be alive and without known major birth defects or chromosomal problems.
- Your platelet count is at least 100,000 per microliter of blood.
- You can give written informed consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether taking progesterone can improve outcomes for people with preeclampsia that is being managed without immediate delivery. It’s meant for pregnancies in a specific gestational age window and when both mother and baby are stable enough for “expectant management.”
This trial studies whether extra screening in the first trimester for preeclampsia (dangerous blood pressure problems in pregnancy) can reduce health problems for both the mother and baby. You may be offered a screening plan that helps identify risk earlier so care can be adjusted.
This trial compares two doses of aspirin (75 mg vs 150 mg) to see which is better at preventing preeclampsia in pregnant women at high risk. If you join, you'll take aspirin daily, and researchers will track your blood pressure and pregnancy health.
This trial studies whether using specific blood-pressure medicines can help people with non-severe preeclampsia stay pregnant longer. It aims to improve outcomes by treating blood pressure early while monitoring you and the baby closely.
This trial tests a new medicine, CBP-4888, for pregnant women hospitalized with preeclampsia starting after 20 weeks. The goal is to see if it's safe and how it works for you and your baby, who will be followed for up to 24 months after birth.
This study tests whether measuring certain proteins in the blood (angiogenic factors) can help doctors better manage preeclampsia in women who are 36 to 38 weeks pregnant. The goal is to see if this approach can safely delay delivery and improve outcomes for both mother and baby.
Hear when a new Preeclampsia (PE) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.